In this report, The sepsis diagnostics market has been segmented by technology, product, pathogen, method, test type, end user, and region.
What the Market Looks Like?
The global sepsis diagnostics market is estimated to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1% from 2018 to 2023. Rising prevalence of sepsis across the globe, increasing geriatric population, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis diagnosis during the study period.
On the basis of technology, the global sepsis diagnostic market is segmented into microbiology, molecular diagnostics, immunoassay, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. Biomarkers offer various advantages in the diagnosis of sepsis as they help identify and differentiate bacterial infection from fungal infection and provide early intervention of disease diagnosis.
On the basis of products, the global sepsis diagnostics market is segmented into blood culture media, assays & reagents, instruments, and software. The blood culture media segment is expected to grow at the highest CAGR during the forecast period owing to the increased used of blood culture media as it is the standard method for diagnosis of sepsis across the globe. On the basis of pathogens, the global sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and other pathogens. The bacterial sepsis segment is expected to grow at the highest CAGR during the forecast period growing number of bacterial sepsis cases and increasing number of surgical procedures across the globe.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=92673155
What Drives the Market?
The growth of the global market for Sepsis Diagnostics is primarily influenced by the following factors:
- High Incidence of Sepsis in the Adult Population
- Increasing Incidence of Sepsis in Neonates
- Growing Incidence of Hospital-Acquired Infections
- Increasing Number of Surgical Procedures
- Increasing Burden of Pneumonia
- Influx of Novel Sepsis Diagnostic Products
- Rising Initiatives to Increase the Awareness and Drive the Adoption of Sepsis Diagnostic Tests
- Funding for Sepsis-Related Research Activities
Geographical growth scenario of Sepsis Diagnostics market
Geographically, the sepsis diagnostic market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected register highest growth during the forecast period, owing to the growing prevalence of sepsis in APAC countries, rising focus of global players in this region, developing healthcare infrastructure, and rising government support for sepsis-related research.
Leading market players and strategies adopted
The prominent players in the Sepsis Diagnostics market include bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany). In addition, emerging markets such as China, India, and Brazil are expected to offer significant growth opportunities for market players owing to the rising focus of local governments to improve healthcare infrastructure of countries and the presence of large patient pool.
Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155
